Acute Lymphoblastic Leukemia Clinical Trials in Georgia

Cancer Type = Acute Lymphoblastic Leukemia

Cancer Type = Acute Lymphoblastic Leukemia

There are currently 9 active Acute Lymphoblastic Leukemia clinical trials in Georgia.
2.
A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Cancer Type
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Leukemia, Lymphoma, Neuroblastoma
NCI ID
NCT03236857
Protocol IDs
M13-833
NCI-2017-02027
2017-000439-14
4.
A Phase I Trial of Temsirolimus (CCI-779, Pfizer, Inc.) in Combination With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Cancer Type
Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma
NCI ID
NCT01614197
Protocol IDs
T2014-001
NCI-2012-01493
T2008-004
6.
NCORP Trial
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Cancer Type
Acute Lymphoblastic Leukemia, Leukemia
NCI ID
NCT02003222
Protocol IDs
NCI-2013-02229
ECOG-E1910
E1910
U10CA021115
U10CA180820
8.
Matched Targeted Therapy (MTT) Recommendation for Patients with Recurrent, Refractory, or High Risk Leukemias
Cancer Type
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Leukemia, Lymphoma, Myelodysplastic Syndromes (MDS)
NCI ID
NCT02670525
Protocol IDs
15-384
NCI-2016-00336
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.